[Chemotherapy of herpetic infections].
D000212:Acyclovir / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004660:Encephalitis / Q000188:drug therapy; D005260:Female; D006168:Guinea Pigs; D006558:Herpes Genitalis / Q000188:drug therapy; D006560:Herpes Labialis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy; D051379:Mice; D010746:Phosphonoacetic Acid / Q000627:therapeutic use; D011817:Rabbits; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000998:Antiviral Agents; C020235:brivudine; D012254:Ribavirin; D014740:Vidarabine; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D010746:Phosphonoacetic Acid; D000212:Acyclovir
Khimioterapiia gerpeticheskoĭ infektsii.